[1]
A. T. G. Moura, F. B. Duarte, M. C. Barbosa, T. E. de J. dos Santos, and R. P. G. Lemes, “Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil”, Clinics, vol. 74, p. e771, May 2019, doi: 10.6061/clinics/2019/e771.